hit counter
AC Immune SA (ACIU) Stock News Sentiment & Price - Sentifly
ACIU - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



AC Immune SA (ACIU)

Switzerland
Biotechnology
NASDAQ
ACIU Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
ACIU Latest news
GlobeNewsWire
Neutral
AC Immune to Present at the Jefferies London Healthcare Conference
2021-10-25 07:00

LAUSANNE, Switzerland, Oct. 25, 2021 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that Company management will participate in a fireside chat and one-on-one investor meetings during the virtual portion of the Jefferies London Healthcare Conference, taking place November 18-19, 2021.

GuruFocus
Positive
Alzheimer's Drug for Roche Partner AC Immune Shows Promise
2021-09-16 14:54

The ardor for shares of AC Immune SA ( ACIU , Financial) has cooled considerably since the company's Aug. 31 announcement of somewhat promising study results for its Alzheimer's drug. The Swiss biotech's stock shot up to a 52-week high of $12.61, but has since been halved as investors questioned how meaningful the trial results were.

GlobeNewsWire
Neutral
AC Immune CEO Andrea Pfeifer Receives First SEF.WomenAward for CEO of the Year
2021-09-03 07:52

LAUSANNE, Switzerland, Sept. 03, 2021 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced its Co-Founder and CEO Andrea Pfeifer has been awarded by the Swiss Economic Forum (SEF) with the SEF.WomenAward, in the category CEO of the Year, during a ceremony at the SEF meeting in Interlaken on September 2, 2021.

GlobeNewsWire
Neutral
AC Immune to Participate in Upcoming Virtual Investor Conferences in September
2021-09-02 07:00

LAUSANNE, Switzerland, Sept. 02, 2021 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that company management will participate in the following upcoming virtual investor conferences:

Zacks Investment Research
Positive
AC Immune's (ACIU) Stock Up Despite Mixed Data From AD Study
2021-09-01 13:47

AC Immune's (ACIU) candidate for mild-to-moderate AD meets one of the two co-primary endpoints. Resultantly, the stock price rises 16%

Benzinga
Positive
What Leerink, Wainwright Have To Say For This Alzheimer's Focused Firm
2021-08-31 15:40

Earlier today, AC Immune SA (NASDAQ:ACIU) announced semorinemab met one of its co-primary endpoints in a mid-stage Alzheimer's disease trial. SVB Leerink notes that semorinemab data is "good news.

InvestorPlace
Positive
ACIU Stock: The Big Alzheimer's News That Has AC Immune Skyrocketing Today
2021-08-31 12:30

AC Immune (ACIU) stock is rising higher on Tuesday after revealing positive results from a recent Alzheimer's disease study. The post ACIU Stock: The Big Alzheimer's News That Has AC Immune Skyrocketing Today appeared first on InvestorPlace.

The Motley Fool
Positive
Here's Why AC Immune Stock Is Surging Today
2021-08-31 11:06

MIxed results for the company's Alzheimer's disease candidate are good enough for the market today.

Schaeffers Research
Positive
Biopharmaceutical Stock Blasts Higher on Alzheimer's Treatment Update
2021-08-31 10:51

The shares of Switzerland-based biopharmaceutical company AC Immune SA (NASDAQ:ACIU) are soaring this morning, up 72.4% to trade at $12.04 at last check.

Pulse2
Positive
ACIU Stock: Over 65% Increase Pre-Market Explanation
2021-08-31 08:27

The stock price of AC Immune SA (NASDAQ: ACIU) increased by over 65% pre-market. This is why it happened.

Loading more news...